Graham R Foster

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 3

Top Topics

Prognostic Factors

Combination Therapy

Top Venues

Alimentary pharmacology & therapeutics

Addiction (Abingdon, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Kathryn Drysdale, Yevedzo Ntuli, Jonathan Bestwick, William Gelson, Geoffrey Dusheiko, Daniel M Forton, David Mutimer, Ahmed Mohamed Elsharkawy, Ceri Townley, Faizel Mahomed, Graham R Foster
English hepatitis C registry data show high response rates to directly acting anti-virals, even if treatment is not completed. Alimentary pharmacology & therapeutics 52 (1) (2020)
Graham R Foster, Tarik Asselah, Sarah Kopecky-Bromberg, Yang Lei, Armen Asatryan, Roger Trinh, Neddie Zadeikis, Federico J Mensa
Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or older. PloS one 14 (1) (2019)
Graham I Harrison, Karen Murray, Roxanne Gore, Penelope Lee, Aravamuthan Sreedharan, Paul Richardson, Amanda J Hughes, Martin Wiselka, Will Gelson, Esther Unitt, Karen Ratcliff, Annette Orton, Kerry Trinder, Charlotte Simpson, Stephen D Ryder, Sandra Oelbaum, Graham R Foster, Archie Christian, Stuart Smith, Brian J Thomson, Rosy Reynolds, Magdalena Harris, Matthew Hickman, William Lucien Irving
The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus-infected people who inject drugs in England. Addiction (Abingdon, England) 114 (6) (2019)